These data not only reveal an epigenetic mechanism for retrograde regulation of cellular metabolism via modulating mitochondrial function by metabolic enzyme NNMT and epigenetic modifier but also demonstrate that NNMT/DNMT1 might be used as biomarkers for mitochondrial OXPHOS targeting cancer therapies. This evidence concerns the gene DNMT1 and cancer.